Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/44162
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorToro Londoño, Miguel Ángel-
dc.contributor.authorde Lucio, Héctor-
dc.contributor.authorCamarasa, María José-
dc.contributor.authorVelázquez, Sonsoles-
dc.contributor.authorGago, Federico-
dc.contributor.authorJiménez Ruiz, Antonio-
dc.date.accessioned2024-12-18T14:50:10Z-
dc.date.available2024-12-18T14:50:10Z-
dc.date.issued2020-
dc.identifier.citationde Lucio H, Toro MA, Camarasa MJ, Velázquez S, Gago F, Jiménez-Ruiz A. Pseudoirreversible slow-binding inhibition of trypanothione reductase by a protein-protein interaction disruptor. Br J Pharmacol. 2020 Nov;177(22):5163-5176. doi: 10.1111/bph.15250.spa
dc.identifier.issn0007-1188-
dc.identifier.urihttps://hdl.handle.net/10495/44162-
dc.description.abstractABSTRACT: Background and purpose: Peptide P4 was described as a dimerization disruptor of trypanothione reductase (TryR), a homodimeric enzyme essential for survival of trypanosomatids. Determination of the true inhibitory constant (Ki ) for P4 was not achieved because reaction rates continuously decreased with time, even when substrate concentration was kept constant. The aim of this study was to find a suitable kinetic model that could allow characterization of the complex pattern of TryR inhibition caused by P4. Experimental approach: After showing the slow-binding and pseudoirreversible activity of P4 against Leishmania infantum trypanothione reductase (Li-TryR), analysis of the curvatures of the reaction progress curves at different inhibitor concentrations allowed us to define the apparent inhibitory constants (Kiapp ) at five different substrate concentrations. Analysis of the changes in Kiapp values allowed precise definition of the type of inhibition. Key results: Li-TryR inhibition by P4 requires two sequential steps that involve rapid generation of a reversible enzyme-inhibitor complex followed by a pseudoirreversible slow inactivation of the enzyme. Recovery of enzyme activity after inhibitor dissociation is barely detectable. P4 is a non-competitive pseudoirreversible inhibitor of Li- TryR that displays an overall inhibition constant (Ki* ) smaller than 0.02 μM. Conclusion and implications: Li-TryRdimer disruption by peptide P4 is a pseudoirreversible time-dependent process which is non-competitive with respect to the oxidized trypanothione (TS2 ) substrate. Therefore, unlike reversible Li-TryR competitive inhibitors, enzyme inhibition by P4 is not affected by the TS2 accumulation observed during oxidant processes such as the oxidative burst in host macrophages.spa
dc.format.extent14 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherMacmillian Journals Ltdspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titlePseudoirreversible slow-binding inhibition of trypanothione reductase by a protein-protein interaction disruptorspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupGrupo de Parasitología, Universidad de Antioquiaspa
dc.identifier.doi10.1111/bph.15250-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1476-5381-
oaire.citationtitleBritish journal of pharmacology.spa
oaire.citationstartpage5163spa
oaire.citationendpage5176spa
oaire.citationvolume177spa
oaire.citationissue22spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc-nd/4.0/spa
oaire.fundernameConsejería de Educación e Investigación. Comunidad de Madridspa
oaire.fundernameMinisterio de Trabajo y Economía Socialspa
oaire.fundernameConsejo Superior de Investigaciones Científicasspa
dc.publisher.placeLondres, Inglaterraspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsDimerización-
dc.subject.decsDimerization-
dc.subject.decsInhibidores Enzimáticos-
dc.subject.decsEnzyme Inhibitors-
dc.subject.decsLeishmania infantum-
dc.subject.decsNADH NADPH Oxidorreductasas-
dc.subject.decsNADH, NADPH Oxidoreductases-
dc.subject.decsTrypanosomatina-
dc.description.researchgroupidCOL0007506spa
oaire.awardnumberS-2018/BAA-4370spa
oaire.awardnumberSAF2015-64629-C2spa
oaire.awardnumber201980E028spa
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D019281-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D004791-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D018314-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D009247-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D014351-
dc.relation.ispartofjournalabbrevBr J Pharmacolspa
oaire.funderidentifier.rorRoR:00t864161-
oaire.funderidentifier.rorRor:01ccvt456-
oaire.funderidentifier.rorRoR:02gfc7t72-
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
ToroMiguel_2020_Pseudoirreversible_Slow‐binding_Inhibition.pdfArtículo de investigación4.83 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons